Technology is the root cause of the cell and gene therapy sector’s manufacturing challenges, according to Ori Biotech CEO, Jason Foster, who points out that it is also the solution. Production ...

Editor’s Note: Hans Keirstead has started six high-tech health companies, including Aivita Biomedical to develop stem cell applications and Immunis Inc. to help people improve their immunity with a ...

An equine cell therapy manufacturing process that uses vertical bioreactors could help the wider industry reduce production and ultimately product costs, according to the authors of a new study. The ...

BEIJING, Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. (SISI) ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the ...